FIELD: medicine; carcinology.
SUBSTANCE: method includes 2-4 presurgical chemotherapy courses within 14 days implying intravenous injections of adriamycin of daily dose 30 mg/m in 1st and 8th day and intramuscular injections of cyclophosphan of daily dose 100 mg/m2 during 14 days. Intervals between courses are 28 days. In addition course implies oral introduction of xeloda of daily dose 2000 mg/m2 twice a day. Method ensures reduction of total chemotherapy toxicity owing to selective activation of medicines directly inside of tumour tissue, and makes possible to perform organ preserving surgical treatment.
EFFECT: reduction of total chemotherapy toxicity; organ preserving surgical treatment.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH OPERABLE MAMMARY GLAND CANCER | 2004 |
|
RU2288710C2 |
METHOD OF TREATMENT OF PATIENTS WITH DISSEMINATED FORMS OF BREAST CANCER | 1996 |
|
RU2131734C1 |
METHOD FOR TREATING PATIENTS POSSESSING DIFFUSE FORMS OF MAMMARY GLAND CARCINOMA | 1996 |
|
RU2133607C1 |
METHOD FOR TREATING THE CASES OF MAMMARY GLAND CARCINOMA | 1996 |
|
RU2134111C1 |
METHOD FOR PREDICTION OF COMPLETE MORPHOLOGICAL REGRESSIONS IN PATIENTS SUFFERING TRIPLE-NEGATIVE RESECTABLE BREAST CANCER | 2014 |
|
RU2560707C1 |
METHOD FOR PERSONALIZED ASSIGNMENT OF NEOAJUVANT CHEMOTHERAPY TO PATIENTS SUFFERING FROM LUMINAL TYPE B BREAST CANCER | 2015 |
|
RU2594251C1 |
METHOD OF PREDICTING ACHIEVEMENT OF COMPLETE MORPHOLOGICAL REGRESSIONS IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER, WHO OBTAINED CHEMOTHERAPY COURSES IN CAX REGIMEN | 2014 |
|
RU2563180C1 |
METHOD OF PREDICTING EFFICIENCY OF NEOADJUVANT CHEMICAL THERAPY IN PATIENTS WITH RESECTABLE BASAL-LIKE TRIPLE-NEGATIVE BREAST CANCER | 2013 |
|
RU2538638C1 |
METHOD FOR HEMATOGENIC METASTASING PREDICTION IN CASE OF NON-SPECIFIC INVASIVE CARCINOMA OF BREAST IN PATIENTS WITH GOOD RESPONSE TO NEOADJUVANT CHEMOTHERAPY | 2016 |
|
RU2627649C1 |
METHOD FOR TREATING THE CASES OF MAMMALIAN GLAND CARCINOMA | 2001 |
|
RU2203687C2 |
Authors
Dates
2008-06-10—Published
2006-06-15—Filed